Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) Equity Average (2022 - 2025)

Cellebrite DI's Equity Average history spans 4 years, with the latest figure at $466.0 million for Q4 2025.

  • Quarterly Equity Average rose 46.93% to $466.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $466.0 million through Dec 2025, up 46.93% year-over-year, with the annual reading at $410.2 million for FY2025, 121.57% up from the prior year.
  • Equity Average came in at $466.0 million for Q4 2025, up from $428.0 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $466.0 million in Q4 2025 to a low of -$42.8 million in Q1 2022.
  • The 4-year median for Equity Average is $56.6 million (2023), against an average of $187.0 million.
  • Year-over-year, Equity Average tumbled 93.37% in 2024 and then soared 9219.4% in 2025.
  • Cellebrite DI's Equity Average stood at -$42.8 million in 2022, then skyrocketed by 184.32% to $36.1 million in 2023, then surged by 779.14% to $317.2 million in 2024, then skyrocketed by 46.93% to $466.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Equity Average are $466.0 million (Q4 2025), $428.0 million (Q3 2025), and $386.0 million (Q2 2025).